Viewing Study NCT02382406


Ignite Creation Date: 2025-12-26 @ 2:42 PM
Ignite Modification Date: 2026-02-09 @ 7:03 AM
Study NCT ID: NCT02382406
Status: TERMINATED
Last Update Posted: 2023-05-23
First Post: 2015-02-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC
Sponsor: Nisha Mohindra, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MK-3475 View
None Pembrolizumab View
None Carboplatin View
None Nab-paclitaxel View